ReviewRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Primary gallbladder melanoma - a rare entity or a diagnostic pitfall?
Review in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary gastrointestinal (GI) melanoma is an exceptionally rare and controversial diagnostic entity. Because the mucosa of the gallbladder, stomach, small bowel, and large bowel is not considered a common site of melanocytic proliferation, most GI melanomas are regarded as metastatic lesions originating from a primary cutaneous melanoma. Whether some of these tumors may truly arise primarily in GI sites remains a matter of debate. The diagnosis is further complicated by the possibility of occult, clinically subtle, or amelanotic cutaneous melanomas that may remain unrecognized until advanced metastatic disease becomes symptomatic. In addition, spontaneous regression of the primary cutaneous lesion may lead to complete or partial disappearance of the original tumor, creating further diagnostic uncertainty. We performed a literature review focused on GI and gallbladder melanoma, with emphasis on the distinction between primary and metastatic lesions and the role of spontaneous regression. In addition, we analyzed all cases of GI and gallbladder melanoma diagnosed in our department during the last five years. Three cases were identified: one gallbladder melanoma and two small bowel melanomas. These cases illustrated distinct clinical scenarios, including GI bleeding associated with gallbladder involvement, amelanotic ileal melanoma, and intussusception caused by metastatic melanoma from a known cutaneous primary lesion. Our findings support the need for cautious interpretation when diagnosing primary GI melanoma. Metastatic disease from occult, regressed, or previously undiagnosed cutaneous melanoma should always be carefully excluded through multidisciplinary clinicopathological evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.